Urate as a predictor of the rate of clinical decline in Parkinson disease.
Archives of Neurology.
Times cited: 182
Increased levels of γ-glutamylamines in Huntington disease CSF.
Journal of Neurochemistry.
Times cited: 42
Metabolomics: A new approach towards identifying biomarkers and therapeutic targets in CNS disorders.
Times cited: 3